Unitat de Nutrició i Salut Pública, Research Group in Nutrition and Mental Health (NUTRISAM), Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain.
Public Health Nutr. 2013 Aug;16(8):1371-8. doi: 10.1017/S1368980013000608. Epub 2013 Mar 11.
To describe the prevalence of iron depletion (ID), iron-deficiency anaemia (IDA) and risk of haemoconcentration during pregnancy and at delivery and to assess the influence of initial Fe stores and Fe supplementation on that prevalence.
Longitudinal study.
Hospital Universitari Sant Joan de Reus (Catalonia, Spain).
Two hundred and eighty-five pregnant women. Serum ferritin and Hb were measured in the first, second and third trimesters and at delivery. Women were classified according to initial Fe stores as ID or no ID (serum ferritin $12mg/l) and according to Fe supplement use as supplemented or nonsupplemented.
Initial ID was 16.2%. At delivery, 45.7% had ID, 13.5% IDA and 13.3% had risk of haemoconcentration. Initial ID and non-supplemented groups had significantly higher prevalences of ID and IDA and lower risk of haemoconcentration at delivery than the other groups. In the multiple logistic models, no initial ID and Fe supplementation exerted a protective effect against ID at delivery (adjusted OR50.28; 95% CI 0.13, 0.58 and adjusted OR50.39; 95% CI 0.22, 0.69, respectively). Moderate Fe supplementation did not seem to clearly prevent IDA (adjusted OR50.91; 95% CI 0.42, 1.96) or to enhance the haemoconcentration (adjusted OR51.42; 95% CI 0.58, 3.50).
The prevalence of ID and IDA was high in late pregnancy in healthy pregnant women, particularly in those with initial ID and/or those not taking supplements. Starting pregnancy with no ID and/or taking moderate Fe supplementation decreased the likelihood of ID at delivery. The risk of haemoconcentration was high at delivery, but did not seem to be promoted by Fe supplementation. Further research is necessary to determine the most appropriate nutritional advice for pregnant women.
描述妊娠和分娩期间铁缺乏(ID)、缺铁性贫血(IDA)和血液浓缩风险的流行情况,并评估初始铁储备和铁补充对这种流行情况的影响。
纵向研究。
西班牙(加泰罗尼亚)Sant Joan de Reus 大学医院。
285 名孕妇。在孕早期、孕中期和孕晚期以及分娩时测量血清铁蛋白和 Hb。根据初始铁储备,女性分为 ID 或非 ID(血清铁蛋白<12mg/l),根据铁补充剂的使用情况,分为补充或非补充。
初始 ID 为 16.2%。分娩时,45.7%有 ID,13.5%有 IDA,13.3%有血液浓缩风险。与其他组相比,初始 ID 和非补充组在分娩时 ID 和 IDA 的发生率显著更高,血液浓缩的风险显著更低。在多因素逻辑回归模型中,无初始 ID 和铁补充对分娩时 ID 具有保护作用(调整后的 OR50.28;95%CI 0.13, 0.58 和调整后的 OR50.39;95%CI 0.22, 0.69)。中度铁补充似乎并不能明显预防 IDA(调整后的 OR50.91;95%CI 0.42, 1.96)或增强血液浓缩(调整后的 OR51.42;95%CI 0.58, 3.50)。
在健康孕妇的晚期妊娠中,ID 和 IDA 的患病率较高,尤其是在有初始 ID 和/或未服用补充剂的孕妇中。妊娠时无 ID 和/或服用中度铁补充剂可降低分娩时 ID 的可能性。分娩时血液浓缩的风险较高,但似乎不受铁补充的影响。需要进一步研究以确定孕妇最适当的营养建议。